Nucleophilic Cobalt Photocatalysis and Organic Single-Electron Photoreductants; Two Enabling Approaches for Chemical Synthesis
Project Number1R35GM154751-01
Contact PI/Project LeaderPITRE, SPENCER
Awardee OrganizationOKLAHOMA STATE UNIVERSITY STILLWATER
Description
Abstract Text
Nucleophilic Cobalt Photocatalysis and Organic Single-Electron Photoreductants; Two Enabling
Approaches for Chemical Synthesis – Project Summary
The objectives of this proposal are two-fold and include the development and fundamental advancement of
nucleophilic cobalt photocatalysis and organic single-electron photoreductants. The unifying theme of these two
distinct proposed research programs is the expansion of the breadth of carbon radical precursors available to
practitioners of synthetic organic chemistry. The successful completion of both objectives will positively and
fundamentally impact the field of chemical synthesis by giving medicinal chemists new synthetic methods that
provide access to new chemical space, thereby benefiting human health.
While carbon-centered radicals have become an increasingly important tool in organic synthesis, the breadth of
radical precursors available to synthetic chemists remains underdeveloped. One underutilized strategy for radical
generation is the use of nucleophilic catalysts to engage electrophiles as radical precursors. We hypothesize
that simple cobaloxime complexes can serve as nucleophilic photocatalysts for the visible-light-generation of
carbon-centered radicals from non-traditional electrophilic precursors including haloforms, electron-deficient
alkenes, iminium ions, vinyl halides and triflates, and primary alcohols. Cobaloximes are among the strongest
nucleophiles known when in the Co(I) oxidation state and can undergo classical substitution reactions with
electrophiles. The resulting alkyl–cobaloximes can undergo facile homolytic cleavage when irradiated with visible
light to generate carbon-centered radicals. This work will advance our understanding of the reactivity of these
cobaloxime complexes, allowing for the development of more efficient catalytic processes that can access new
classes of radical precursors, enabling new bond disconnection strategies for organic synthesis.
To further advance the field of radical chemistry, general approaches that serve to generate radicals directly
from readily available alkyl halides and carbonyl compounds which circumvent the use of tin hydrides and ground
state metal reductants would be of great value. We hypothesize that organic single-electron photoreductants can
serve as a general platform for visible-light-mediated radical generation directly from unactivated precursors.
Our approach will be enabled by two distinct strategies: namely, halogen-bonding photocatalysis and 1,4-
dihydropyridine (DHP) anion photoreductants. For our halogen-bonding photocatalysis approach, our substituted
hydroquinone catalysts directly engage with carbon–halide bonds via a halogen-bonding interaction, leading to
a catalytically generated electron donor-acceptor complex that can be activated by visible-light irradiation. This
work is expected to lead to a general strategy for radical generation from a broad range of alkyl halide precursors,
yielding methods that have unprecedented functional group tolerance. For our second approach, we hypothesize
that simple 1,4-DHPs in the presence of a suitable base can serve as potent excited state reductants. Our work
on 1,4-DHP anions will lead to a mild and operationally simple method for ketyl radical formation, which has
been shown to be valuable synthetic intermediates in the synthesis of complex, highly functionalized compounds.
Public Health Relevance Statement
Project Narrative/Public Health Relevance Statement
The ability to rapidly synthesize a diverse array of chemical structures is critical for the discovery and
manufacture of new pharmaceuticals. This work aims to provide two enabling technologies, nucleophilic cobalt
catalysis and organic single-electron photoreductants, for the rapid and efficient construction of carbon–carbon
bonds. The methods enabled by these technologies will provide new tools for practitioners of medicinal
chemistry, streamlining drug discovery and development and thereby positively impacting human health.
No Sub Projects information available for 1R35GM154751-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R35GM154751-01
Patents
No Patents information available for 1R35GM154751-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R35GM154751-01
Clinical Studies
No Clinical Studies information available for 1R35GM154751-01
News and More
Related News Releases
No news release information available for 1R35GM154751-01
History
No Historical information available for 1R35GM154751-01
Similar Projects
No Similar Projects information available for 1R35GM154751-01